Scientists find new way to up safety factor of stem cell therapy
04 October, 2012Researchers at the Mayo Clinic have found a way to detect and purge stem cells at risk of developing into tumours.
Nanotechnology device aims to prevent malaria deaths through rapid diagnosis
02 October, 2012A pioneering mobile device using cutting-edge nanotechnology to rapidly detect malaria infection and drug resistance could revolutionise how the disease is diagnosed and treated.
I can hear big pharma screaming
24 September, 2012A systematic review of the effects of antihypertensive drug therapy on people with mild hypertension has found no benefits come with the drugs. If this review is accurate, big pharma won’t be happy and the government will be thrilled.
Genetic test predicts risk for autism
18 September, 2012A team of Australian researchers, led by the University of Melbourne, has developed a genetic test that is able to predict the risk of developing Autism Spectrum Disorder (ASD).
Flu is transmitted before symptoms appear, study suggests
31 August, 2012Research at Imperial College London examining influenza transmission in ferrets suggests that the virus can be passed on before the appearance of symptoms. If the finding applies to humans, it means that people pass on flu to others before they know they’re infected, making it very difficult to contain epidemics.
Researchers develop DNA sequencing tests for hereditary diseases
22 August, 2012Scientists at the University of Medicine and Dentistry of New Jersey-New Jersey Medical School (UMDNJ-NJMS) have developed DNA sequencing tests that hold significant promise for decreasing costs associated with diagnosing cancer and hereditary diseases, including cystic fibrosis.
Olympic lab leaves life sciences legacy
14 August, 2012The London 2012 anti-doping facilities, operated by King’s College London, will be developed after the Olympic and Paralympic Games into a world-class resource that could help revolutionise healthcare.
Major breakthrough in hepatitis C vaccine development
14 August, 2012Researchers at the Burnet Institute have solved a hepatitis C vaccine mystery which, once developed, could be the first ever preventative vaccine for the virus.
Busselton people help type 2 diabetes world research
13 August, 2012Busselton residents and researchers from The University of Western Australia have contributed to a worldwide scientific collaboration that has identified new genetic links in the quest to map the biological pathways that cause diabetes.
New bat virus could hold key to Hendra virus
08 August, 2012Australian scientists have discovered a new virus in bats that could help shed light on how Hendra and Nipah viruses cause disease and death in animals and humans.
Lifting malaria’s deadly veil: mystery solved in quest for vaccine
02 August, 2012Researchers at the Burnet Institute have made a major breakthrough in the quest for a vaccine against malaria, which causes up to one million deaths each year.
Putting smokers’ oxidative stress levels under the microscope
25 July, 2012A new study investigating the effectiveness of live blood analysis (LBA) as a tool to measure oxidative stress is being conducted at Southern Cross University and smokers are being invited to take part.
CSIRO to supply essential antibodies in the search for new rotavirus vaccines
19 July, 2012CSIRO has been contracted by PATH (Program for Appropriate Technology in Health) to produce antibodies on a large scale that will aid the development of new, safe, affordable and effective vaccines against rotavirus, a major cause of severe and fatal diarrhoea in young children worldwide.
Chicken vaccines recombine to produce virulent viruses
13 July, 2012New Australian research showing that poultry vaccines have recombined to produce more virulent viruses has prompted the Australian Pesticides and Veterinary Medicines Authority (APVMA) to examine regulatory controls over the approval and use of veterinary vaccines.
Non-invasive genetic test for Down syndrome and Edwards syndrome highly accurate
13 June, 2012Current screening strategies for Down syndrome, caused by foetal trisomy 21 (T21), and Edwards syndrome, caused by foetal trisomy 18 (T18), have false positive rates of 2 to 3%, and false negative rates of 5% or higher. Now an international, multicentre cohort study finds that a genetic test to screen for trisomy 21 or 18 from a maternal blood sample is almost 100% accurate.
